Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Jaco Voorham, Bernard Vrijens, Job FM van Boven, Dermot Ryan, Marc Miravitlles, Lisa M Law & David B Price. (2017) Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort study. Pragmatic and Observational Research 8, pages 31-41.
Read now
Read now
Henry Covelli, Bonavuth Pek, Isabelle Schenkenberger, Catherine Scott-Wilson, Amanda Emmett & Courtney Crim. (2016) Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 1-12.
Read now
Read now
Amal Bhattacharya, Salil Bhargava, Virendra Singh, Deepak Talwar, Jagdeep Whig, Juliet Rebello, Shrinivas Purandare & Jaideep Gogtay. (2016) Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 1469-1476.
Read now
Read now
Eleftherios Zervas, Konstantinos Samitas & Mina Gaga. (2016) Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 1845-1855.
Read now
Read now
Timothy E Albertson, Richart Harper, Susan Murin & Christian Sandrock. (2015) Patient considerations in the treatment of COPD: focus on the new combination inhaler umeclidinium/vilanterol. Patient Preference and Adherence 9, pages 235-242.
Read now
Read now
James F Davidson, James F Donohue & Jill A Ohar. (2015) Umeclidinium/vilanterol combination inhaler efficacy and potential impact on current chronic obstructive pulmonary disease management guidelines. Expert Opinion on Drug Safety 14:2, pages 317-324.
Read now
Read now
A. Ismaila, D. Corriveau, J. Vaillancourt, D. Parsons, A. Dalal, Z. Su & J.S. Sampalis. (2014) Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients. Current Medical Research and Opinion 30:7, pages 1427-1436.
Read now
Read now
Articles from other publishers (29)
Tracey J. Weiss, Dena Rosen Ramey, Lingfeng Yang, Xinyue Liu, Mahesh J. Patel, Swapnil Rajpathak, Ednan K. Bajwa & Dominik Lautsch. (2022) Medication use by US patients with pulmonary hypertension associated with chronic obstructive pulmonary disease: a retrospective study of administrative data. BMC Pulmonary Medicine 22:1.
Crossref
Crossref
Constança Monteiro, Tiago Maricoto, Filipe Prazeres, Pedro Augusto Simões & José Augusto Simões. (2022) Determining factors associated with inhaled therapy adherence on asthma and COPD: A systematic review and meta-analysis of the global literature. Respiratory Medicine 191, pages 106724.
Crossref
Crossref
Eiji Shiwaku, Satoshi Dote, Shinobu Kaneko, Chisato Hei, Masaki Aikawa, Yuki Sakai, Takahiro Kawai, Shigeaki Iwatsubo, Michinobu Hashimoto, Teppei Tsuneishi, Tomoko Nishimura, Toshiyuki Iwata, Daiki Hira, Tomohiro Terada, Takashi Nishimura & Yuka Kobayashi. (2021) Pharmacist involvement in the inhaler choice improves lung function in patients with COPD: a prospective single-arm study. Journal of Pharmaceutical Health Care and Sciences 7:1.
Crossref
Crossref
Jessica P. Hollenbach, Tregony Simoneau, Ye Sun, Iris Becene, Sigrid Almeida, Christine Langton & Glenn Flores. (2021) Design, methods, and baseline characteristics of a pilot, randomized, controlled trial of the effects of an electronic monitoring device on medication adherence in children with asthma. Contemporary Clinical Trials Communications 21, pages 100706.
Crossref
Crossref
Suhaj Abdulsalim, Mazhuvancherry Kesavan Unnikrishnan, Mohan K. Manu, Saud Alsahali, Alian A. Alrasheedy, Antony P. Martin, Brian Godman & Abubakr A. Alfadl. (2019) Impact of a Clinical Pharmacist Intervention on Medicine Costs in Patients with Chronic Obstructive Pulmonary Disease in India. PharmacoEconomics - Open 4:2, pages 331-342.
Crossref
Crossref
F. Dalon, E. Van Ganse, C. Correia Da Silva, G. Nachbaur, L. Saïl & M. Belhassen. (2019) Revue générale sur l’adhésion aux traitements inhalés de la BPCO. Revue des Maladies Respiratoires 36:7, pages 801-849.
Crossref
Crossref
Suhaj Abdulsalim, Mazhuvancherry Kesavan Unnikrishnan, Mohan K. Manu, Alian A. Alrasheedy, Brian Godman & Donald E. Morisky. (2018) Structured pharmacist-led intervention programme to improve medication adherence in COPD patients: A randomized controlled study. Research in Social and Administrative Pharmacy 14:10, pages 909-914.
Crossref
Crossref
Ellen Ingrid Schafheutle, Tom Fegan & Darren M. Ashcroft. (2018) Exploring medicines management by COPD patients and their social networks after hospital discharge. International Journal of Clinical Pharmacy 40:5, pages 1019-1029.
Crossref
Crossref
Agnieszka Sliwka, Milosz Jankowski, Iwona Gross-Sondej, Monika Storman, Roman Nowobilski & Malgorzata M Bala. (2018) Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2018:8.
Crossref
Crossref
Juan C. Celedón, Esteban G. Burchard, Dean Schraufnagel, Carlos Castillo-Salgado, Marc Schenker, John Balmes, Enid Neptune, Kristin J. Cummings, Fernando Holguin, Kristin A. Riekert, Juan P. Wisnivesky, Joe G. N. Garcia, Jesse Roman, Rick Kittles, Victor E. Ortega, Susan Redline, Rasika Mathias, Al Thomas, Jonathan Samet & Jean G. Ford. (2017) An American Thoracic Society/National Heart, Lung, and Blood Institute Workshop Report: Addressing Respiratory Health Equality in the United States. Annals of the American Thoracic Society 14:5, pages 814-826.
Crossref
Crossref
Agnieszka Sliwka, Milosz Jankowski, Iwona Gross-Sondej, Roman Nowobilski & Malgorzata M Bala. (2016)
Once daily Long-acting beta
2
-agonists/Inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease
. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Melinde R.S. Boland, Job F.M. van Boven, Annemarije L. Kruis, Niels H. Chavannes, Thys van der Molen, Lucas M.A. Goossens & Maureen P.M.H. Rutten-van Mölken. (2016) Investigating the association between medication adherence and health-related quality of life in COPD: Methodological challenges when using a proxy measure of adherence. Respiratory Medicine 110, pages 34-45.
Crossref
Crossref
Sandra R. Wilson, Meghan Halley & Sarah Knowles. 2016. Health Disparities in Respiratory Medicine. Health Disparities in Respiratory Medicine
105
133
.
Melissa H. Roberts, Douglas W. Mapel, Matthew E. Borrego, Dennis W. Raisch, Larry Georgopoulos & David van der Goes. (2015) Severe COPD Exacerbation Risk and Long-Acting Bronchodilator Treatments: Comparison of Three Observational Data Analysis Methods. Drugs - Real World Outcomes 2:2, pages 163-175.
Crossref
Crossref
Alessandro Sanduzzi, Piero Balbo, Piero Candoli, Giousuè A Catapano, Paola Contini, Alessio Mattei, Giovanni Puglisi, Luigi Santoiemma & Anna A Stanziola. (2014) COPD: adherence to therapy. Multidisciplinary Respiratory Medicine 9:1.
Crossref
Crossref
Mark T. Dransfield, Gregory Feldman, Phillip Korenblat, Craig F. LaForce, Nicholas Locantore, Massimo Pistolesi, Michael L. Watkins, Courtney Crim & Fernando J. Martinez. (2014) Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients. Respiratory Medicine 108:8, pages 1171-1179.
Crossref
Crossref
Lonneke M. Boer, Leonie Daudey, Jeannette B. Peters, Johan Molema, Judith B. Prins & Jan H. Vercoulen. (2013) Assessing the Stages of the Grieving Process in Chronic Obstructive Pulmonary Disease (COPD): Validation of the Acceptance of Disease and Impairments Questionnaire (ADIQ). International Journal of Behavioral Medicine 21:3, pages 561-570.
Crossref
Crossref
Douglas W. Mapel & Melissa H. Roberts. (2014) Management of Asthma and Chronic Obstructive Pulmonary Disease with Combination Inhaled Corticosteroids and Long-Acting β-Agonists: A Review of Comparative Effectiveness Research. Drugs 74:7, pages 737-755.
Crossref
Crossref
Henry Chrystyn, Mark Small, Gary Milligan, Victoria Higgins, Esther Garcia Gil & Jordi Estruch. (2014) Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPD. Respiratory Medicine 108:2, pages 358-365.
Crossref
Crossref
Job F.M. van Boven, Niels H. Chavannes, Thys van der Molen, Maureen P.M.H. Rutten-van Mölken, Maarten J. Postma & Stefan Vegter. (2014) Clinical and economic impact of non-adherence in COPD: A systematic review. Respiratory Medicine 108:1, pages 103-113.
Crossref
Crossref
Alexandre Trifilieff, Steven J. Charlton & Robin A. Fairhurst. 2014. Indacaterol. Indacaterol
25
37
.
Jingjing Qian, Linda Simoni‐Wastila, Gail B. Rattinger, Ilene H. Zuckerman, Susan Lehmann, Yu‐Jung J. Wei & Bruce Stuart. (2013) Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease. International Journal of Geriatric Psychiatry 29:1, pages 49-57.
Crossref
Crossref
Henrik Svedsater, Peter Dale, Karl Garrill, Richard Walker & Mark W Woepse. (2013) Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD. BMC Pulmonary Medicine 13:1.
Crossref
Crossref
Katherine A. Lyseng-Williamson & Natalie J. Carter. (2013) Inhaled glycopyrronium bromide: a guide to its use in moderate to severe chronic obstructive pulmonary disease. Drugs & Therapy Perspectives 29:12, pages 367-372.
Crossref
Crossref
Natalie J. Carter. (2013) Inhaled Glycopyrronium Bromide: A Review of its Use in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease. Drugs 73:7, pages 741-753.
Crossref
Crossref
Hideaki Mochizuki, Yuta Nanjo & Hideki Takahashi. (2012) Better adherence to a transdermal tulobuterol patch than inhaled salmeterol in elderly chronic obstructive pulmonary disease patients. Geriatrics & Gerontology International 13:2, pages 398-404.
Crossref
Crossref
David Price, Amanda J Lee, Erika J Sims, Linda Kemp, Elizabeth V Hillyer, Alison Chisholm, Julie von Ziegenweidt & Angela Williams. (2013) Characteristics of patients preferring once-daily controller therapy for asthma and COPD: a retrospective cohort study. Primary Care Respiratory Journal 22:2, pages 161-168.
Crossref
Crossref
Linda Simoni-Wastila, Jingjing Qian, Yu-Jung Jenny Wei, Bruce Stuart, Ilene H Zuckerman, Thomas Shaffer, Anand A Dalal & Lynda Bryant-Comstock. (2012) Should Medicare rely on high drug spending as a criterion for medication therapy management programmes?. Journal of Pharmaceutical Health Services Research 3:4, pages 213-219.
Crossref
Crossref
Linda Simoni-Wastila, Yu-Jung Wei, Jingjing Qian, Ilene H. Zuckerman, Bruce Stuart, Thomas Shaffer, Anand A. Dalal & Lynda Bryant-Comstock. (2012) Association of Chronic Obstructive Pulmonary Disease Maintenance Medication Adherence With All-Cause Hospitalization and Spending in a Medicare Population. The American Journal of Geriatric Pharmacotherapy 10:3, pages 201-210.
Crossref
Crossref